Outcomes of umbilical cord transplant in high risk relapsed or refractory acute myeloid leukaemia

被引：0
|
作者：
Elbahy, Samar [1 ,2 ]
Bonney, Denise [1 ]
Campbell, Helen [1 ]
Deambrosis, David [1 ]
Wynn, Robert [1 ]
机构：
[1] Royal Manchester Childrens Hosp, Manchester, Lancs, England
[2] Benha Univ, Fac Med, Banha, Egypt
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P718
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [31] Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia
    Hotinski, Anya K.
    Lewis, Ian D.
    Ross, David M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (09) : 1395 - 1402
  • [32] Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
    Baez-Gutierrez, Nerea
    Rodriguez-Ramallo, Hector
    Antonia-Perez Moreno, Maria
    Arboli, Eduardo-Rodriguez
    Abdel-Kader Martin, Laila
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [33] Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia
    Jamy, Omer
    Lin, Karen
    Worth, Sarah
    Bachiashvili, Kimo
    Rangaraju, Sravanti
    Vachhani, Pankit
    Bhatia, Ravi
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (03) : E35 - E37
  • [34] Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia
    Kugler, Eitan
    Cohen, Inbar
    Amitai, Irina
    Ram, Ron
    Frisch, Avraham
    Nachmias, Boaz
    Canaani, Jonathan
    Moshe, Yakir
    Krayem, Baher
    Aumann, Shlomzion
    Henig, Israel
    Vainstein, Vladimir
    Shargian, Liat
    Ganzel, Chezi
    Yeshurun, Moshe
    Levi, Itay
    Raanani, Pia
    Akria, Luiza
    Ofran, Yishai
    Shimony, Shai
    Wolach, Ofir
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (03) : 932 - 941
  • [35] A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia
    Zeidan, Amer M.
    Smith, B. Douglas
    Carraway, Hetty E.
    Gojo, Ivana
    DeZern, Amy
    Gore, Steven D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (02) : 241 - 247
  • [36] Necrotising dermatitis in refractory acute myeloid leukaemia
    D'Apollo, N
    Saviola, A
    Longo, G
    Luppi, M
    Emilia, G
    Torelli, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (06) : 464 - 465
  • [37] Conditioning regimens for refractory acute myeloid leukaemia
    Majhail, Navneet S.
    LANCET HAEMATOLOGY, 2015, 2 (09): : E354 - E355
  • [38] Granulocytic Sarcoma in an Adult with Relapsed Acute Myeloid Leukaemia
    Kurien, Neethu Ann
    John, Deepa
    Chack, Geeta
    Jacob, Pushpa
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (01) : ND3 - ND4
  • [39] Prognostic significance of cytogenetics in relapsed acute myeloid leukaemia
    Kern, W
    Schoch, C
    Hiddemann, W
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) : 671 - 672
  • [40] Creating a standardised approach for relapsed acute myeloid leukaemia
    Coombes, JL
    Davies, M
    Dennis, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S373 - S374
12345